Vaso-occlusive Crisis Clinical Trials

28 clinical trials for Vaso-occlusive Crisis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease — RECRUITING · NA
• Oral Ketamine for Treatment of Vaso-Occlusive Pain — RECRUITING · PHASE3
• Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA) — RECRUITING
• Hyperbaric Oxygen Therapy in Sickle Cell Pain — COMPLETED · NA
• Non Invasive Positive Pressure Ventilation for Prevention of Acute Chest Syndrome in Sickle Cell Disease — TERMINATED · NA
• Nitrous Oxide Analgesia Vaso-occlusive Crisis — COMPLETED · PHASE2
• A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease — TERMINATED · PHASE3
• A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises — COMPLETED · PHASE3
• Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease — NOT_YET_RECRUITING
• Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease — COMPLETED
• A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises — TERMINATED · PHASE3
• Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED — TERMINATED · PHASE3
• Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric — NOT_YET_RECRUITING · PHASE3
• Validation of a Predictive Score of Acute Chest Syndrome — OTHER
• Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) — OTHER · PHASE3
• Evaluation of Virtual Reality to Save Morphinic in the Treatment of Vaso-occlusive Seizures of Sickle Cell Patients Consulting in the Emergency Room — COMPLETED · NA
• Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis — COMPLETED · PHASE2
• Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease — TERMINATED · PHASE3
• Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia — COMPLETED · PHASE2
• Steroid Treatment for Sickle Cell Pain Crisis — TERMINATED · PHASE3
• Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis — COMPLETED · PHASE2
• Apixaban in Patients With Sickle Cell Disease — TERMINATED · PHASE3
• Music Therapy in Sickle Cell Disease Vaso-occlusive Crisis — OTHER · NA
• Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC) — WITHDRAWN · PHASE2
• Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC) — COMPLETED · PHASE3
• Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo — COMPLETED · PHASE2
• A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. — TERMINATED · PHASE2
• IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome — COMPLETED · PHASE2

Refine this search